Angela Birnbaum

Title: Angela Birnbaum: Innovator in Parenteral Formulations

Introduction

Angela Birnbaum is a notable inventor based in Minneapolis, MN (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the area of parenteral administration of medications. With a total of 2 patents, her work has the potential to enhance the efficacy and safety of drug delivery systems.

Latest Patents

Angela's latest patents focus on a parenteral carbamazepine formulation. This invention is directed towards a carbamazepine-cyclodextrin inclusion complex that is useful for the parenteral administration of carbamazepine. The formulation is prepared by mixing a modified cyclodextrin with carbamazepine in a physiologically acceptable fluid. The modified cyclodextrins used include 2-hydroxypropyl-beta-cyclodextrin and sulfoalkyl cyclodextrins. The sulfoalkyl cyclodextrins are specifically those described in U.S. Pat. Nos. 5,134,127 and 5,376,645. The physiologically acceptable fluids suitable for this formulation include sterile isotonic water, Ringer's lactate, D5W (5% dextrose in water), physiological saline, and similar fluids.

Career Highlights

Throughout her career, Angela has worked with reputable companies such as Lundbeck Pharmaceuticals LLC and Lundbeck Inc. Her experience in these organizations has allowed her to develop innovative solutions in the pharmaceutical industry.

Collaborations

Angela has collaborated with esteemed colleagues, including Ilo Leppik and Stephen D Collins. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Angela Birnbaum is a pioneering inventor whose work in parenteral formulations is making a significant impact in the pharmaceutical field. Her innovative approaches to drug delivery continue to pave the way for advancements in patient care.